Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jun
28
2022
Senate Committee Passes the FDA Safety and Landmark Advancements Act Keller and Heckman LLP
Mar
8
2019
USDA and FDA Provide Additional Details on Joint Regulation of Cell-Cultured Meat Keller and Heckman LLP
Mar
13
2019
FDA Extends HPHC Reporting Deadline for Deemed Tobacco Products Keller and Heckman LLP
Jul
14
2022
FDA Approves Six Accreditation Bodies Under LAAF Keller and Heckman LLP
Mar
19
2019
‘Dairy Pride Act’ Introduced Again Keller and Heckman LLP
Jul
25
2022
Proposed Rule Could Make Sugarcane Subject to the Same National Bioengineered Food Disclosure Standard Burdens as Sugarbeet Keller and Heckman LLP
Aug
18
2022
FDA Publishes Pesticide Residue Report for FY 2020 Keller and Heckman LLP
Apr
18
2019
51st Meeting of the Codex Alimentarius Committee on Food Additives (CCFA51) Finalizes Most of Its Backlog on Food Additives Keller and Heckman LLP
May
17
2019
European Food Safety Authority Responds to French Ban of Titanium Dioxide in Food Keller and Heckman LLP
Oct
4
2022
Chocolate Report Released regarding Lead and Cadmium Keller and Heckman LLP
Jun
13
2019
E-Vapor Industry Coalition Formally Opposes CPSC Novel Interpretation of CNPPA that Immediately Requires Flow-Restricted Packaging for E-Liquids Keller and Heckman LLP
Nov
10
2022
IFSAC Releases Report on Foodborne Illnesses Keller and Heckman LLP
Jun
19
2019
FDA Issues Final Guidance on Declaration of Added Sugars for Honey, Maple Syrup, Etc. Keller and Heckman LLP
Jun
24
2019
EFSA Publishes Guidance on the TTC Approach Keller and Heckman LLP
Nov
22
2022
California Votes “Yes” on Proposition 31 Banning the Retail Sale Non-Tobacco Flavored Tobacco Products Keller and Heckman LLP
Jun
26
2019
Data Disclosure: Will The New GFL Ensure Transparency Without Jeopardizing EU Competitiveness? Keller and Heckman LLP
Jul
8
2019
Upcoming Public Workshop to Provide Update on FDA’s Predictive Toxicology Roadmap Keller and Heckman LLP
Dec
16
2022
FTC Starts Long-Awaited Green Guides Review Keller and Heckman LLP
Jul
18
2019
Grated Parmesan Cheese Companies Can’t Escape Food Fraud Litigation on Excess Cellulose Keller and Heckman LLP
Jan
17
2023
Court Rules that “Brown Bread” is Not Misleading Keller and Heckman LLP
Aug
1
2019
Upcoming Legislation to Address Plastic Waste Keller and Heckman LLP
Aug
20
2019
Japan Notifies WTO of its New Positive List for Plastic Food-Contact Materials Keller and Heckman LLP
Feb
28
2023
FDA Asked to Allow “Healthy” Claims on Coffee Keller and Heckman LLP
Aug
29
2019
Green Chemistry 2018–2019: A Review of the Year That Was and Predictions for the Remainder of 2019 Keller and Heckman LLP
Mar
13
2023
FDA Publishes Proposed Rule on Tobacco Product Manufacturing Practices Keller and Heckman LLP
Sep
12
2019
San Francisco’s Fluorinated Chemical Ban Limited to Compostable Food Service Ware Keller and Heckman LLP
Sep
20
2019
CBD Food And Drink Products In The EU: The Newest Hot Commodity Or A Regulatory Headache? Keller and Heckman LLP
Apr
10
2023
Plaintiffs Argue There is No Evidence FDA Will Act Soon on “Natural” Definition Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins